BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

492 related articles for article (PubMed ID: 27431984)

  • 1. Immunological Consequences of Epithelial-Mesenchymal Transition in Tumor Progression.
    Chockley PJ; Keshamouni VG
    J Immunol; 2016 Aug; 197(3):691-8. PubMed ID: 27431984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunosuppressive cells in tumor immune escape and metastasis.
    Liu Y; Cao X
    J Mol Med (Berl); 2016 May; 94(5):509-22. PubMed ID: 26689709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Revisiting epithelial-mesenchymal transition in cancer metastasis: the connection between epithelial plasticity and stemness.
    Liao TT; Yang MH
    Mol Oncol; 2017 Jul; 11(7):792-804. PubMed ID: 28649800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New insights into the role of EMT in tumor immune escape.
    Terry S; Savagner P; Ortiz-Cuaran S; Mahjoubi L; Saintigny P; Thiery JP; Chouaib S
    Mol Oncol; 2017 Jul; 11(7):824-846. PubMed ID: 28614624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interplay of Immunometabolism and Epithelial-Mesenchymal Transition in the Tumor Microenvironment.
    Chou MY; Yang MH
    Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Vicious Cross-Talk between Tumor Cells with an EMT Phenotype and Cells of the Immune System.
    Romeo E; Caserta CA; Rumio C; Marcucci F
    Cells; 2019 May; 8(5):. PubMed ID: 31096701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Cancer Cell Dissemination Machinery as an Immunosuppressive Niche: A New Obstacle Towards the Era of Cancer Immunotherapy.
    Asiry S; Kim G; Filippou PS; Sanchez LR; Entenberg D; Marks DK; Oktay MH; Karagiannis GS
    Front Immunol; 2021; 12():654877. PubMed ID: 33927723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epithelial-mesenchymal transition leads to NK cell-mediated metastasis-specific immunosurveillance in lung cancer.
    Chockley PJ; Chen J; Chen G; Beer DG; Standiford TJ; Keshamouni VG
    J Clin Invest; 2018 Apr; 128(4):1384-1396. PubMed ID: 29324443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular Characterization of Circulating Tumor Cells to Study Cancer Immunoevasion.
    Nicolazzo C; Gradilone A; Carpino G; Gazzaniga P; Raimondi C
    Methods Mol Biol; 2019; 1884():247-258. PubMed ID: 30465208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Antitumor Cytotoxic Response: If the Killer Cells Play the Music, the Microenvironmental Hypoxia Plays the Tune.
    Chouaib S
    Crit Rev Immunol; 2020; 40(2):157-166. PubMed ID: 32749093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TGF-β-induced epithelial-mesenchymal transition: a link between cancer and inflammation.
    Fuxe J; Karlsson MC
    Semin Cancer Biol; 2012 Oct; 22(5-6):455-61. PubMed ID: 22627188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of Hypoxic Stress in Regulating Tumor Immunogenicity, Resistance and Plasticity.
    Terry S; Faouzi Zaarour R; Hassan Venkatesh G; Francis A; El-Sayed W; Buart S; Bravo P; Thiery J; Chouaib S
    Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30301213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The tumor microenvironment: An irreplaceable element of tumor budding and epithelial-mesenchymal transition-mediated cancer metastasis.
    Li H; Xu F; Li S; Zhong A; Meng X; Lai M
    Cell Adh Migr; 2016 Jul; 10(4):434-46. PubMed ID: 26743180
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor Immune Microenvironment during Epithelial-Mesenchymal Transition.
    Taki M; Abiko K; Ukita M; Murakami R; Yamanoi K; Yamaguchi K; Hamanishi J; Baba T; Matsumura N; Mandai M
    Clin Cancer Res; 2021 Sep; 27(17):4669-4679. PubMed ID: 33827891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor microenvironment and noncoding RNAs as co-drivers of epithelial-mesenchymal transition and cancer metastasis.
    Drak Alsibai K; Meseure D
    Dev Dyn; 2018 Mar; 247(3):405-431. PubMed ID: 28691356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of complement-dependent cytotoxicity by TGF-β-induced epithelial-mesenchymal transition.
    Goswami MT; Reka AK; Kurapati H; Kaza V; Chen J; Standiford TJ; Keshamouni VG
    Oncogene; 2016 Apr; 35(15):1888-98. PubMed ID: 26148233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epithelial-mesenchymal transition in cancer metastasis through the lymphatic system.
    Karlsson MC; Gonzalez SF; Welin J; Fuxe J
    Mol Oncol; 2017 Jul; 11(7):781-791. PubMed ID: 28590032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TGF-β and EGF induced HLA-I downregulation is associated with epithelial-mesenchymal transition (EMT) through upregulation of snail in prostate cancer cells.
    Chen XH; Liu ZC; Zhang G; Wei W; Wang XX; Wang H; Ke HP; Zhang F; Wang HS; Cai SH; Du J
    Mol Immunol; 2015 May; 65(1):34-42. PubMed ID: 25618241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxystressed tumor microenvironment potentiates epithelial to mesenchymal transition and alters cellular bioenergetics towards cancer progression.
    Sridaran D; Ramamoorthi G; MahaboobKhan R; Kumpati P
    Tumour Biol; 2016 Oct; 37(10):13307-13322. PubMed ID: 27460079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epithelial-to-mesenchymal transition and autophagy induction in breast carcinoma promote escape from T-cell-mediated lysis.
    Akalay I; Janji B; Hasmim M; Noman MZ; André F; De Cremoux P; Bertheau P; Badoual C; Vielh P; Larsen AK; Sabbah M; Tan TZ; Keira JH; Hung NT; Thiery JP; Mami-Chouaib F; Chouaib S
    Cancer Res; 2013 Apr; 73(8):2418-27. PubMed ID: 23436798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.